
Off-grid solar now reaches 149 million people—up 26% in two years.
Small solar systems are powering homes, jobs and 7.4 million microenterprises.
Every serving. No expiration date.

Small solar systems are powering homes, jobs and 7.4 million microenterprises.

A 130-metre electric ferry is now carrying passengers and vehicles across the Río de la Plata.

The planned 40% price cut could save about $50 million over three years.

Economic security and rainforest stewardship rose together in three Indigenous communities—but the pilot had no control group.

The rule targets excessive distribution markups while requiring manufacturers to maintain supply.

A government parking lot is becoming a small, flexible power system.

A school-leaving law became rare causal evidence that social policy can shape brain health decades later.

A few strategically bare loops replaced a forest of compromises.

A more precise signal gave exhausted treatment paths one more opening.

Stable housing, VA care and support services are being built together.

Child care relief is moving from pilot to citywide scale.

More clean capacity arrived—and midday wholesale power got cheaper.

A local law turns a family-support promise into paid time.

Six implementation projects and one study will test cleaner equipment from landfill methane sensors to factory batteries.

The system reasoned through 304 difficult cases step by step, but the result is still a benchmark—not patient care.

A parent-led preschool and Spanish-immersion campaign helped Daniel Webster Elementary grow into a thriving neighborhood school.

One positron. Months of control. A new precision tool for fundamental physics.

One tumor. One recipe. A 42% lower relative risk.

A circuit map hints that plasticity and hallucination may not be inseparable.

Big storage. Lower bills.

Exercise kept the heart inside the Mars envelope.

Housing stability may be health care.

In trials, 24% met treatment-stopping criteria versus none on placebo; 19% stayed controlled 24 weeks after stopping all therapy.

In an ongoing trial, nearly three-quarters had not needed the usual treatments after a median of more than two years.